Gene Expression Study on Similarity Effect of Thymoquinone on Epithelial Breast Cancer and Colorectal Cancer Cell Lines
American Journal of Life Sciences
Volume 3, Issue 2-2, March 2015, Pages: 1-6
Received: Dec. 9, 2014; Accepted: Dec. 17, 2014; Published: Dec. 27, 2014
Views 2895      Downloads 162
Author
Marjaneh Motaghed, Oncology Science Cluster, Advanced Medical and Dental Institute, University Sains Malaysia, Penang, Malaysia
Article Tools
Follow on us
Abstract
Adenocarcinoma is known as a common type of cancer which includes 85% of breast carcinoma and 95% of colorectal carcinoma. Up until now, the cytotoxic effect of Thymoquinone on different types of tumor cells has been reported. It was hypothesized that Thymoquinone has similar effect on cancer arising from epithelial cells through gene expression analysis in MCF7 breast cancer and HT-29 colon cancer cell lines. The quantity and quality of RNA samples were identified using RNeasyPlus Mini kit and RNA 6000 Nano LabChip kit, respectively. The purified RNA samples of MCF7 cells were used in two-color 8×60K cDNA array platform with SurePrint Agilent technology. The hybridized cRNA/cDNA probes were identified due to labeling with red and green cyanine dyes using GEX hybridization buffer HI-RPM. LOWESS normalization reduced the dye bias on the array slide using feature extraction software. Gene ontology analysis was done after performing different steps of filtering to reduce not satisfied genes using Gene Spring software. Two-step RT-qPCR assay using Taq Man fast advanced master mix analyzed the most up and down regulated genes in MCF7 compared to HT-29 cancer cell lines. The 10 different cancer cell lines in a form of universal reference RNA was used as standard data set comparison and as a positive control RNA in cDNA array and RT-qPCR assay, respectively. The T-test statistical analysis of independent samples showed that there is no significant difference between two types of cell lines due to Thymoquinone treatment with p-value 0.844. Among the selected genes; CARD16, UGT1A8, SLC7A11, IFIT1, IF16 and IFIT3 were expressed significantly (0.009, 0.0001, 0.037, 0.098, 0.0001 and 0.033, respectively) in breast cancer compare to colon cancer cells. The findings indicated similar effect of Thymoquinone on cancer arising from epithelial cells.
Keywords
Thymoquinone, Epithelial Cancer Cells, cDNA Array, RT-qPCR Assay
To cite this article
Marjaneh Motaghed, Gene Expression Study on Similarity Effect of Thymoquinone on Epithelial Breast Cancer and Colorectal Cancer Cell Lines, American Journal of Life Sciences. Special Issue: The Most Effective Medicinal Plants in Cancer Treatment. Vol. 3, No. 2-2, 2015, pp. 1-6. doi: 10.11648/j.ajls.s.2015030202.11
References
[1]
National Cancer Institute, Global Cancer Research Programs. 2013. [Online]. Available at:
[2]
Torres, M.P., Ponnusamy, M.P., Chakraborty, S., Smith, L.M., Das, S., Arafat, H.A., Batra, S.K., 2010. Effects of Thymoquinone in the Expression of Mucin 4 in Pancreatic Cancer Cells: Implications for the Development of Novel Cancer Therapies. Molecular Cancer Therapy 9, 1419-1431.
[3]
Woo, C.C., Loo, S.Y., Gee, V., Yap, C.W., Sethi, G., Kumar, A. P., Benny, T., Huat, K., 2011. Anticancer activity of Thymoquinone in breast cancer cells: Possible involvement of PPAR-[gamma] pathway. Biochemical Pharmacology 82, 464-75.
[4]
Gali-Muhtasib, H., Diab-Assaf, M., Boltze, C., Al-Hmaira, J., Hartig, R., Roessner, A., Schneider-Stock, R., 2004a. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. International Journal Oncology 25, 857-66.
[5]
Kaseb, A., Chinnakannu, K., Chen, D., Sivanandam, A., Tejwani, S., Menon, M., Dou, Q., Reddy, G., 2007. Androgen receptor and E2F-1 targeted Thymoquinone therapy for hormone-refractory prostate cancer. Cancer Research 67, 7782-8.
[6]
Roepke, M., Diestel, A., Bajbouj, K., Walluscheck, D., Schonfeld, P., Roessner, A., Schneider-Stock, R., Gali-Muhtasib, H., 2007. Lack of p53 augments Thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biology and Therapy 6, 160-169.
[7]
Dongsheng, X.U., Yong, M.A., Baolei, Z., Shuai, Li, Yu, Z., Shangha P., Yaohua, W.U., Jizhou, W., Dawei, W., Huayang P., Lianxin, L., Jiang, H., 2014. Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo. Oncology Reports 31, 2063-2070.
[8]
Wenchuan, Q., Xu, S., Ling, L., 2013. Long non-coding RNA-guided regulation in organisms. Science China Life Sciences 56, 891-896.
[9]
Broad Institute., 2010. Human Body Map lincRNA. Human lincRNA catalog [Online]. Available at:
[10]
Wang, X., Wang, H., Figueroa, B., Zhang, W., Huo, C., Guan, Y., Zhang, Y., Bruey, J., Reed, J., Friendlander, R., 2005. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington's disease. Journal Neuroscience 25, 11645-54
[11]
El-Najjar, N., Chatila, M., Moukadem, H., Vuorela, H., Ocker, M., Gandesiri, M., Schneider-Stock, R., Gali-Muhtasib, H., 2010. Reactive oxygen species mediate Thymoquinone- induced apoptosis and activate ERK and JNK signalling. Apoptosis 15, 183-195.
[12]
NCBI Resources., 2014. Gene. [Online]. Available at:
[13]
Li, X., Bratton, S., Radominska-Pandya, A., 2007. Human UGT1A8 and UGT1A10 mRNA Are Expressed In Primary Human Hepatocytes. Drug Metabolism Pharmacokinetic 22, 152–161.
[14]
Wu, Y., Zhang, X., Bardag-Gorce, F., Robel, R.C.V., Aguilo, J., Chen, L., Zeng, Y., Hwang, K., French, S.W., Lu, S.C., Wan, Y.J.Y., 2004. Retinoid X Receptor α Regulates Glutathione Homeostasis and Xenobiotic Detoxification Processes in Mouse Liver. Mol Pharmacol 65, 550-557.
[15]
Liska, D.J., 1998. The Detoxification Enzyme Systems. Alternative Medicine Review 3, 187-198.
[16]
NextPort Beta., 2014. Exploring the universe of human proteins[Online].Available at :
[17]
Sinicropi, D., Cronin, M., Liu, M., 2007. Gene Expression Profiling Utilizing Microarray Technology and RT-PCR. Genomic Health, Inc., Redwood City, California USA. [Online]. Available at:
[18]
The Human Gene Compendium. (2014). GeneCards [Online]. Available at:>http://www.genecards.org/. accessed on 28th May 2014.
[19]
Pham, A.N., Blower, P.E., Alvarado, O., Ravula, R., Gout, P. W., Huang, Y., 2010. Pharmacogenomic Approach Reveals a Role for the xc− Cystine/Glutamate Antiporter in Growth and Celastrol Resistance of Glioma Cell Lines. Journal of Pharmacology and Experimental Therapeutics 332, 949-958.
[20]
Huang, Y., Dai, Z., Barbacioru, C., Sadee, W., 2005. Cystine-Glutamate Transporter SLC7A11 in Cancer Chemosensitivity and Chemo resistance. Cancer Research 65, 7446-7454.
[21]
Amin, A., Gali-Muhtasib, H., Ocker, M., Schneider-Stock, R. 2009. Overview of Major Classes of Plant-Derived Anticancer Drugs. Internationa Journal Biomedical Science 5, 1-11.
[22]
Alhosin, M., Abusnina, A., Achour, M., Sharif, T., Muller, C., Peluso, J., Chataigneau, T., Lugnier, C., Schini-Kerth, V. B., Bronner, C. & Fuhrmann, G., 2010. Induction of apoptosis by Thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1. Biochemical Pharmacology 9, 1251-1260.
[23]
Koka, P.S., Mondal, D., Schultz, M., Abdel-Mageed., Agrawal, K.C., 2010. Studies on molecular mechanisms of growth inhibitory effects of Thymoquinone against prostate cancer cells: role of reactive oxygen species. Experimental Biology and Medicine 235, 751-760.
[24]
Hussain, A.R., Ahmed, M., Ahmed, S., Manogaran, P., Platanias, L., Alvi, S., Al-Kuraya, K., Uddin, S., 2011. Thymoquinone suppresses growth and induces apoptosis via generation of reactive oxygen species in primary effusion lymphoma. Free Radical Biology & Medicine 50, 978-987.
[25]
Landa, S.Z., Mohan, S., Othman, R., Abdelwahab, S.I., Kamalidehghan, B., Sheikh, B.Y., Ibrahim, M.Y., 2013. Thymoquinone Induces Mitochondria-Mediated Apoptosis in Acute Lymphoblastic Leukaemia in Vitro Molecules 18, 11219-11240.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186